Patient Blood Management - Use and Outcome (PBM-USZ)

November 10, 2020 updated by: University of Zurich
Study the influence of transfusion related Patient Blood Management Program actions on transfusion-related outcome measures and cost.

Study Overview

Status

Completed

Conditions

Detailed Description

At the University Hospital of Zurich, an in-house designed monitoring and feedback system was introduced which electronically registers each transfusion of any allogeneic blood product, be it red blood cells, plasma or platelets as well as corresponding laboratory data. Results are reported quarterly to Department heads. The investigator analyzes whether the introduction of this monitoring and feedback system as part of a patient blood management Program has a significant influence on use of allogeneic blood product transfusions and transfusion-related costs, without compromising patient outcome.

Study Type

Observational

Enrollment (Actual)

250000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
      • Zurich, Switzerland, 8091
        • University Hospital Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All cases of all in hospital patients. Area of Focus: Transfusions of blood products.

Description

Inclusion Criteria:

  • Only case records, all discharged patients of the University Hospital of Zürich

Exclusion Criteria:

  • Not discharged from our Hospital.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
All Health Conditions.
All Health Conditions. Area of Focus: Transfusions of blood products.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of transfusions per participant
Time Frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years
Participant wich had transfusion will be identified and the administrative, financial and clinical data will be compared to participants without transfusions
participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of transfusion of any blood product per participant
Time Frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years
Count of any blood products per case, QM Data
participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years
Cost of any blood product per participant
Time Frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years
costs per case
participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years
Survey of Patient Blood Management System
Time Frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years
clinical, financial,and administrative data of all participants will be reviewed on the focus on transfusions
participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Zurich

Investigators

  • Principal Investigator: Donat R Spahn, Prof, IFA University Hospital Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2012

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

December 1, 2019

Study Registration Dates

First Submitted

May 11, 2015

First Submitted That Met QC Criteria

June 11, 2015

First Posted (Estimate)

June 16, 2015

Study Record Updates

Last Update Posted (Actual)

November 12, 2020

Last Update Submitted That Met QC Criteria

November 10, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KEK 2015-0175

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemorrhage

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe